Rob Conley is the Senior Vice President for Clinical Development at Eleusis. He recently retired from Eli Lilly and Co. where he served as the Chief Science Officer from late phase Neuroscience. Prior to that he had a long academic career, first at the University of Pittsburgh and then at the University of Maryland School of Medicine. He remains an Adjunct Professor of Psychiatry and Psychopharmacology at Maryland.
Rob holds an MD from the University of Maryland School of Medicine and a BA from the Johns Hopkins University. He completed a Psychiatry residency at the University of Pittsburgh, where he served as the Chief Resident. Rob is also a Fellow of the American College of Neuropsychopharmacology.
Current role
Mollie Leoni
SVP, Clinical Development at Kura Oncology
Cherry Thomas
SVP, Clinical Development at Caribou Biosciences
Paul Chamberlin
SVP, Clinical Development at Imbria Pharmaceuticals
Kelly Blackburn
SVP, Clinical Development at EIP Pharma
Judy Chiao
SVP, Clinical Development at Vigeo Therapeutics
Bhaskar Srivastava
SVP, Clinical Development at Nimbus Therapeutics